3mna: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
[[Image:3mna.png|left|200px]] | [[Image:3mna.png|left|200px]] | ||
{{STRUCTURE_3mna| PDB=3mna | SCENE= }} | {{STRUCTURE_3mna| PDB=3mna | SCENE= }} | ||
===The crystal structure of human carbonic anhydrase Ii in complex with a 1,3,5-triazine-substituted benzenesulfonamide inhibitor=== | ===The crystal structure of human carbonic anhydrase Ii in complex with a 1,3,5-triazine-substituted benzenesulfonamide inhibitor=== | ||
{{ABSTRACT_PUBMED_21515057}} | {{ABSTRACT_PUBMED_21515057}} | ||
| Line 22: | Line 11: | ||
==See Also== | ==See Also== | ||
*[[Carbonic anhydrase]] | *[[Carbonic anhydrase|Carbonic anhydrase]] | ||
==Reference== | ==Reference== | ||
Revision as of 09:50, 27 July 2012
The crystal structure of human carbonic anhydrase Ii in complex with a 1,3,5-triazine-substituted benzenesulfonamide inhibitor
Template:ABSTRACT PUBMED 21515057
About this Structure
3mna is a 1 chain structure of Carbonic anhydrase with sequence from Homo sapiens. Full crystallographic information is available from OCA.
See Also
Reference
- Carta F, Garaj V, Maresca A, Wagner J, Avvaru BS, Robbins AH, Scozzafava A, McKenna R, Supuran CT. Sulfonamides incorporating 1,3,5-triazine moieties selectively and potently inhibit carbonic anhydrase transmembrane isoforms IX, XII and XIV over cytosolic isoforms I and II: Solution and X-ray crystallographic studies. Bioorg Med Chem. 2011 May 15;19(10):3105-19. Epub 2011 Apr 6. PMID:21515057 doi:10.1016/j.bmc.2011.04.005
